2 results
Approved WMORecruiting
Primary:• To Evaluate the safety and tolerability of tarlatamab • Determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D)Secondary:• Evaluate anti-tumor activity of tarlatamab as assessed by additional measures • Characterize…
Approved WMORecruiting
This project aims to study the effectiveness of adding 18F-FDG PET/MRI to standard clinical care in patients with chronic low back or hip pain.Secondary objectives encompass exploration of the change in metabolic activity on 18F-FDG PET/MRI after…